Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Adicet Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +2 vs. Q2 2022
- Shares held
- 41.5M
- +3.56M (+9.4%) vs. Q2 2022
- Total value
- $590.7M
- +$34.9M (+6.3%) vs. Q2 2022
- New holders
- 21
- 44 more added
- Sold out
- 19
- 21 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 4,241,472 | $60.3M | 1.39% | +290,191+7.3% | Added |
| OrbiMed Advisors LLC | 7,447,140 | $105.9M | 2.10% | −10.0% | Reduced |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −183,857−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −143,214−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −128,666−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −125,500−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −104,900−100.0% | Sold out |
| Jackson Creek Investment Advisors LLC | 0 | $0 | 0.00% | −54,425−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −44,523−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −20,890−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −16,805−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,760−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,317−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −11,772−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,690−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,962−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −5,669−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Cordasco Financial Network | – | – | – | – | Not filed |